Search Results 1711-1720 of 19439 for hemoglobin

1. A Study to Evaluate AL102 to Treat Patients with Progressing Desmoid Tumors - Mayo Clinic

   Hemoglobin \<9 g/dL, 4. Total bilirubin \>1.5x upper limit of normal (ULN) (except known Gilbert's syndrome), 5. Aspartate aminotransferase (AST) and ...

2. A Study To Assess The Safety, Tolerability, And Pharmacokinetics Of ABSK-011 In Patients With Advanced Solid Tumor - Mayo Clinic

   Hemoglobin (Hb) ≥80 g/L. Total bilirubin (TBIL) ≤1.5×ULN. Aspartate transaminase (AST) and alanine transaminase (ALT), ≤3×ULN (for patient with liver ...

3. A Study to Evaluate At Home Administration of Pertuzumab Combined with Trastuzumab to Treat Patients with HER2-Positive Breast Cancer During COVID-19 Pandemic - Mayo Clinic

   Hemoglobin < 9 g/dL. Impaired liver function, defined by any of: Serum (total) bilirubin > 1.25 x upper limit of normal (ULN). In case of Gilbert's syndrome ...

4. Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma - Mayo Clinic

   Hemoglobin \> = 10.0 g/dL 4. Creatinine clearance \>= 60 mL/min calculated by the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) creatinine ...

5. Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In Situ - Mayo Clinic

   - Hemoglobin < 10 g/dL (within 30 days of randomization). - Leukocytes < 3,000/microliter (within 30 days of randomization). - Platelets < 100,000 ...

6. MMRC Horizon One Adaptive Platform Trial Evaluating Therapies In RRMM - Mayo Clinic

   ... hemoglobin ≥ 8 g/dL (transfusion and/or growth factor support is allowed for hematologic parameters as long as the investigator deems the participant ...

7. Phase 2 Study of JK07 in Chronic Heart Failure - Mayo Clinic

   Screening hemoglobin ≥ 9.0 g/dL. Exclusion Criteria: Uncontrolled hypertension. Sustained systolic Blood Pressure (BP) < 90 mmHg and/or diastolic BP < 50 ...

8. A Study of Lutetium Lu 177 Dotatate (Lutathera®) in Patients with Inoperable, Progressive Meningioma after External Beam Radiation Therapy - Mayo Clinic

   * Hemoglobin \>= 9.0 g/dL (obtained =\< 14 days prior to registration) * Direct bilirubin \< 1.5 x upper limit of normal (ULN) (or total bilirubin =\< 3.0 x ...

9. A Study of Cediranib and Olaparib Combined, Compared to Either Drug Alone, or to a Standard Chemotherapy in Treating Patients who have a Return of Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

   Hemoglobin >= 10 g/dL; Total bilirubin within =< 1.5 times the upper limit of normal (ULN) institutional limits; Aspartate aminotransferase (AST) (serum ...

10. A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab - Mayo Clinic

    hemoglobin ≥ 9 g/dL (may have been transfused);; alanine aminotransferase (ALT, SGPT) ≤ 3.5 x upper limit of normal (ULN);; aspartate aminotransferase (AST ...